Cyclooxygenases and bone repair

[1]  C. Vinson,et al.  PTHrP Modulates Chondrocyte Differentiation through AP-1 and CREB Signaling* , 2001, The Journal of Biological Chemistry.

[2]  E. Schwarz,et al.  Evidence for a Direct Role of Cyclo‐Oxygenase 2 in Implant Wear Debris‐Induced Osteolysis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  D. Macdonald,et al.  Nonunion of the femoral diaphysis , 2000 .

[4]  F. Silverstein,et al.  Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor , 2000, American Journal of Gastroenterology.

[5]  S. Patterson,et al.  Early excision of heterotopic bone in the forearm. , 2000, The Journal of hand surgery.

[6]  B. Galer,et al.  A Drug Use Evaluation of Selected Opioid and Nonopioid Analgesics in the Nursing Facility Setting , 2000, Journal of the American Geriatrics Society.

[7]  S. Morham,et al.  Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. , 2000, The Journal of clinical investigation.

[8]  B. Boyan,et al.  24R,25‐(OH)2D3 mediates its membrane receptor‐dependent effects on protein kinase C and alkaline phosphatase via phospholipase A2 and cyclooxygenase‐1 but not cyclooxygenase‐2 in growth plate chondrocytes , 2000, Journal of cellular physiology.

[9]  M. M. Dozier,et al.  Inhibition of prostaglandin synthesis reduces cyclic AMP levels and inhibits chondrogenesis in cultured chick limb mesenchyme. , 2000, Methods in cell science : an official journal of the Society for In Vitro Biology.

[10]  R. DuBois,et al.  Review article: cyclooxygenase – a target for colon cancer prevention , 2000, Alimentary pharmacology & therapeutics.

[11]  L. Titus,et al.  Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. , 1999, Spine.

[12]  O'Banion,et al.  COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration. , 1999, Expert opinion on investigational drugs.

[13]  T. Nishihara,et al.  Effect of prostaglandin E2 on recombinant human bone morphogenetic protein-2-stimulated osteoblastic differentiation in human periodontal ligament cells. , 1999, Journal of periodontal research.

[14]  B. Boyan,et al.  Prostaglandins mediate the effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner. , 1999, Bone.

[15]  T. Kokubu,et al.  Low intensity pulsed ultrasound exposure increases prostaglandin E2 production via the induction of cyclooxygenase-2 mRNA in mouse osteoblasts. , 1999, Biochemical and biophysical research communications.

[16]  D. Dean,et al.  1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2 , 1999, Steroids.

[17]  T. Tsuruo,et al.  Basic fibroblast growth factor induces cyclooxygenase-2 expression in endothelial cells derived from bone. , 1999, Biochemical and biophysical research communications.

[18]  P. Lipsky,et al.  Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. , 1998, Arthritis and rheumatism.

[19]  Gwo‐Jaw Wang,et al.  Effects of Ketorolac on Bone Repair: A Radiographic Study in Modeled Demineralized Bone Matrix Grafted Rabbits , 1998, Pharmacology.

[20]  John R. Johnson,et al.  The Effect of Postoperative Nonsteroidal Anti‐inflammatory Drug Administration on Spinal Fusion , 1998, Spine.

[21]  J. Anglen,et al.  Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: A randomised, prospective study , 1998 .

[22]  D. Zaleske,et al.  Response of physeal cartilage to low-level compression and tension in organ culture. , 1998, Journal of pediatric orthopedics.

[23]  H. Herschman,et al.  Transforming growth factor-beta1 regulation of prostaglandin G/H synthase-2 expression in osteoblastic MC3T3-E1 cells. , 1997, Endocrinology.

[24]  H. Kawaguchi,et al.  Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. , 1997, Endocrinology.

[25]  S. Keila,et al.  Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. , 1997, Bone.

[26]  G. Rodan,et al.  Systemic administration of an anabolic dose of prostaglandin E2 induces early-response genes in rat bones. , 1997, Bone.

[27]  D B Kimmel,et al.  Prostaglandin E2 increases the skeletal response to mechanical loading. , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  S. Reuben,et al.  Ketorolac as an Adjunct to Patient-Controlled Morphine in Postoperative Spine Surgery Patients , 1996, Regional Anesthesia & Pain Medicine.

[29]  I. Ono,et al.  Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by prostaglandin E1. , 1996, Bone.

[30]  M. Forwood,et al.  Inducible cyclo‐oxygenase (COX‐2) mediates the induction of bone formation by mechanical loading in vivo , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  William A. Ante,et al.  The Effects of Nonsteroidal Anti‐inflammatory Drugs on Posterior Spinal Fusions in the Rat , 1996, Spine.

[32]  K Banovac,et al.  Effect of Nonsteroidal Antiinflammatory Drugs on Fracture Healing: A Laboratory Study in Rats , 1995, Journal of orthopaedic trauma.

[33]  M. Hurley,et al.  Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor. , 1995, The Journal of clinical investigation.

[34]  F. Blanco,et al.  Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. , 1995, Journal of immunology.

[35]  M. Fredericson,et al.  Tibial Stress Reaction in Runners , 1995, The American journal of sports medicine.

[36]  L. Raisz,et al.  Autoregulation of inducible prostaglandin G/H synthase in osteoblastic cells by prostaglandins , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  K. Seibert,et al.  Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Kawaguchi,et al.  Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. , 1993, The Journal of biological chemistry.

[39]  B. Bak,et al.  Effect of local prostaglandin E2 on fracture callus in rabbits. , 1993, Acta orthopaedica Scandinavica.

[40]  B. Boyan,et al.  Regulation of prostaglandin E2 production by vitamin D metabolites in growth zone and resting zone chondrocyte cultures is dependent on cell maturation. , 1992, Bone.

[41]  V. Winn,et al.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Puzas,et al.  Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  A. A. Capehart,et al.  Comparative effects of cytosine arabinoside and a prostaglandin E2 antagonist, AH6809, on chondrogenesis in serum-free cultures of chick limb mesenchyme. , 1991, Experimental cell research.

[44]  A. A. Capehart,et al.  Effects of a putative prostaglandlin E2 antagonist, AH6809, on chondrogenesis in serum‐free cultures of chick limb mesenchyme , 1991, Journal of cellular physiology.

[45]  F. Linde,et al.  Heterotopic bone formation after total hip arthroplasty in patients with primary or secondary coxarthrosis. , 1990, Orthopedics.

[46]  L. Raisz,et al.  Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. , 1990, Endocrinology.

[47]  M. M. Dozier,et al.  Responsiveness of adenylate cyclase to PGE2 and forskolin in isolated cells from micromass cultures of chick limb mesenchyme during chondrogenesis. , 1990, Prostaglandins.

[48]  M. M. Dozier,et al.  Phorbol esters inhibit chondrogenesis in limb mesenchyme by mechanisms independent of PGE2 or cyclic AMP1. , 1989, Experimental Cell Research.

[49]  M. M. Dozier,et al.  Inhibition of chondrogenesis by retinoic acid in limb mesenchymal cells in vitro: effects on PGE2 and cyclic AMP concentrations. , 1988, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[50]  L. Sawyer,et al.  Chondrogenesis in chick limb mesenchyme in vitro derived from distal limb bud tips: Changes in cyclic AMP and in prostaglandin responsiveness , 1988, Journal of cellular physiology.

[51]  A. Breckenridge,et al.  Drug-specific antibodies in patients receiving captopril. , 1986, British journal of clinical pharmacology.

[52]  W. Jee,et al.  Effect of 16, 16‐dimethyl prostaglandin E2 methyl ester on weanling rat skeleton: Daily and systemic administration , 1986, The Anatomical record.

[53]  H. Bèzes,et al.  Comparison of the efficacy and tolerance of isoxicam and piroxicam following surgery for skiing accidents. , 1986, British journal of clinical pharmacology.

[54]  R. Kosher,et al.  The effect of prostaglandins on the cyclic AMP content of limb mesenchymal cells. , 1985, Cell differentiation.

[55]  R. Kosher,et al.  The effect of prostaglandins on in vitro limb cartilage differentiation. , 1983, Experimental cell research.

[56]  R. Majeska,et al.  Biosynthesis and metabolism of prostaglandins in chick epiphyseal cartilage. , 1977, Prostaglandins.

[57]  M. Weinreb,et al.  Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae. , 1998, The Journal of endocrinology.

[58]  I. Morita,et al.  Involvement of prostaglandin endoperoxide H synthase-2 in osteoclast formation induced by parathyroid hormone. , 1997, Advances in experimental medicine and biology.

[59]  S. Fuchs,et al.  Evaluation of ketorolac in children with forearm fractures. , 1997, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[60]  W. Jee,et al.  Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. , 1990, Bone.

[61]  K. Giercksky,et al.  Epidemiology of NSAID-related gastrointestinal side effects. , 1989, Scandinavian journal of gastroenterology. Supplement.

[62]  D. Woodbury,et al.  The effects of prostaglandin E2 in rapidly growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass. , 1985, Bone.